454 related articles for article (PubMed ID: 30967685)
1. Nanodrugs used in cancer therapy.
Kopeckova K; Eckschlager T; Sirc J; Hobzova R; Plch J; Hrabeta J; Michalek J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):122-131. PubMed ID: 30967685
[TBL] [Abstract][Full Text] [Related]
2. The Clinical Translation of Organic Nanomaterials for Cancer Therapy: A Focus on Polymeric Nanoparticles, Micelles, Liposomes and Exosomes.
Palazzolo S; Bayda S; Hadla M; Caligiuri I; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4224-4268. PubMed ID: 28875844
[TBL] [Abstract][Full Text] [Related]
3. Nanodrugs: pharmacokinetics and safety.
Onoue S; Yamada S; Chan HK
Int J Nanomedicine; 2014; 9():1025-37. PubMed ID: 24591825
[TBL] [Abstract][Full Text] [Related]
4. Applications of nanosystems to anticancer drug therapy (Part II. Dendrimers, micelles, lipid-based nanosystems).
Ruiz ME; Gantner ME; Talevi A
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):99-128. PubMed ID: 23578193
[TBL] [Abstract][Full Text] [Related]
5. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Drug Delivery: An Update on Clinically Applied Nanotherapeutics.
Marchal S; El Hor A; Millard M; Gillon V; Bezdetnaya L
Drugs; 2015 Sep; 75(14):1601-11. PubMed ID: 26323338
[TBL] [Abstract][Full Text] [Related]
7. Trends in Nanomedicines for Cancer Treatment.
do Nascimento T; Todeschini AR; Santos-Oliveira R; de Souza de Bustamante Monteiro MS; de Souza VT; Ricci-Júnior E
Curr Pharm Des; 2020; 26(29):3579-3600. PubMed ID: 32186271
[TBL] [Abstract][Full Text] [Related]
8. Nanocarriers for anticancer drugs--new trends in nanomedicine.
Drbohlavova J; Chomoucka J; Adam V; Ryvolova M; Eckschlager T; Hubalek J; Kizek R
Curr Drug Metab; 2013 Jun; 14(5):547-64. PubMed ID: 23687925
[TBL] [Abstract][Full Text] [Related]
9. Theranostic liposomes for cancer diagnosis and treatment: current development and pre-clinical success.
Muthu MS; Feng SS
Expert Opin Drug Deliv; 2013 Feb; 10(2):151-5. PubMed ID: 23061654
[TBL] [Abstract][Full Text] [Related]
10. Liposomal therapies in oncology: does one size fit all?
Sousa I; Rodrigues F; Prazeres H; Lima RT; Soares P
Cancer Chemother Pharmacol; 2018 Nov; 82(5):741-755. PubMed ID: 30116847
[TBL] [Abstract][Full Text] [Related]
11. Targeted nanodrugs for cancer therapy: prospects and challenges.
Bottini M; Sacchetti C; Pietroiusti A; Bellucci S; Magrini A; Rosato N; Bottini N
J Nanosci Nanotechnol; 2014 Jan; 14(1):98-114. PubMed ID: 24730253
[TBL] [Abstract][Full Text] [Related]
12. Albumin-Based Nanodevices as Drug Carriers.
Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Mediated Cancer Therapeutics Delivery using Micelles and Liposomes: A Review.
Mukhopadhyay D; Sano C; AlSawaftah N; El-Awady R; Husseini GA; Paul V
Recent Pat Anticancer Drug Discov; 2021; 16(4):498-520. PubMed ID: 34911412
[TBL] [Abstract][Full Text] [Related]
14. Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy.
Piktel E; Niemirowicz K; Wątek M; Wollny T; Deptuła P; Bucki R
J Nanobiotechnology; 2016 May; 14(1):39. PubMed ID: 27229857
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology: Revolutionizing the Science of Drug Delivery.
Mishra M; Kumar P; Rajawat JS; Malik R; Sharma G; Modgil A
Curr Pharm Des; 2018; 24(43):5086-5107. PubMed ID: 30727873
[TBL] [Abstract][Full Text] [Related]
16. Towards clinical translation of ligand-functionalized liposomes in targeted cancer therapy: Challenges and opportunities.
Belfiore L; Saunders DN; Ranson M; Thurecht KJ; Storm G; Vine KL
J Control Release; 2018 May; 277():1-13. PubMed ID: 29501721
[TBL] [Abstract][Full Text] [Related]
17. Polymeric Micelles: Recent Advancements in the Delivery of Anticancer Drugs.
Gothwal A; Khan I; Gupta U
Pharm Res; 2016 Jan; 33(1):18-39. PubMed ID: 26381278
[TBL] [Abstract][Full Text] [Related]
18. Implications of nanotechnology for the treatment of cancer: Recent advances.
Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
[TBL] [Abstract][Full Text] [Related]
19. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
Jain V; Jain S; Mahajan SC
Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
[TBL] [Abstract][Full Text] [Related]
20. [Development of Drug Delivery Technology and Nanomedicine by Using Gold Nanoparticles].
Ozeki T; Tagami T
Yakugaku Zasshi; 2021; 141(3):323-326. PubMed ID: 33642498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
